Arctic Nutrition is to form a scientific collaboration with Norwegian firm Møreforsking to provide marine lipid and cell study expertise in developing its omega-3 fatty acid-enriched herring roe extract.
SternLife is taking on the untapped 'beauty from within' food and drink opportunity with all-natural 'beauty drinks' powders created to help protect from external causes of skin and hair ageing.
Norwegian krill processor Rimfrost is to award a €100m (NOK 1bn) contract to Westcon to build a new krill fishing vessel that enables the production of food supplements at sea immediately after catching.
Royal DSM and French chemical company Metex NØØvista, are to partner up in a research and development deal to deliver a 100% bio-sourced ingredient for skincare products.
BASF Nutrition & Health are teaming up with Ideogen to introduce an omega-3 fatty acid solution to Europe that addresses the chronic condition Non-Alcoholic Fatty Liver Disease (NAFLD).
Chr. Hansen makes available a new three-strain probiotic blend that the Danish bioscience company says can help halve the risk of Necrotising Enterocolitis (NEC) in premature babies.
Italian botanicals firm Indena is to sell its nutricosmetics business to Swiss flavours and fragrances specialist Givaudan in a deal that also involves a manufacturing and innovation partnership between the two firms.
A world-class line up of international experts in the microbiome, probiotics and prebiotics will take centre stage in Dublin this February as Probiota 2020 bridges the science and industry divide.
Nestlé continues to accelerate its efforts in microbiome research as the Swiss multinational announces a partnership with the University of California San Diego Center for Microbiome Innovation (CMI).
Are you a researcher with compelling new data on the microbiome? Do you have exciting probiotic or prebiotic science to share? Would you like to present your findings at the leading microbiome-focused event? If so, today is the last day to submit your...
Croatian firm Atlantic Grupa is to sell two supplement brands to PharmaS in a continuation of the firm’s strategy to “divest non-core business operations and focus on key categories and brands”.
